PT-141 10MG 10 Vial Kit

Bremelanotide, commercially known as PT-141, represents a synthetic melanocortin receptor agonist engineered to target the melanocortin 4 receptor within the central nervous system. This peptide compound is structurally derived from alpha-melanocyte-stimulating hormone, a naturally occurring regulatory molecule. As an MC4R agonist, PT-141 functions through established melanocortin signaling pathways. This 10-vial kit provides a standardized research-grade formulation for laboratory and investigational applications.